Spark Venture Management

Unmarshal operates a decentralized network of blockchain data indexers and transforming tools designed to empower Decentralized Finance (DeFi) applications across various chains.

Study119.com is a professional firefighter education and training service platform.

MyOffer is an online platform focused on facilitating overseas study applications, offering comprehensive information on over one million courses at universities in the United Kingdom, Australia, and beyond. Founded in 2014 and based in London, the company utilizes advanced data analytics to provide personalized course recommendations and assists users in applying to multiple programs simultaneously. MyOffer enables students to filter universities and courses based on their academic backgrounds and personal preferences while also providing guidance on adjusting to life and studies abroad. Additionally, the company aims to expand its services to include visa applications, accommodation assistance, career planning, and employment opportunities for international students. As a subsidiary of UVIC Limited, MyOffer seeks to enhance the overseas education experience for students globally.

Simba Sleep Limited is a London-based company specializing in the design and manufacture of innovative mattresses and sleep-related products. Founded in 2015, it offers a diverse range of foam mattresses that incorporate a unique combination of conical pocket springs and precision-engineered foam, ensuring optimal comfort and support. In addition to mattresses, Simba Sleep provides a variety of sleep accessories, including pillows, duvets, and bed bases, all crafted with advanced materials to enhance sleep quality. The company emphasizes the importance of sleep and aims to help customers achieve restorative rest. Simba Sleep sells its products through select retail partners, notably John Lewis, and also operates a robust online platform for direct consumer sales.

Simba Sleep Limited is a London-based company specializing in the design and manufacture of innovative mattresses and sleep-related products. Founded in 2015, it offers a diverse range of foam mattresses that incorporate a unique combination of conical pocket springs and precision-engineered foam, ensuring optimal comfort and support. In addition to mattresses, Simba Sleep provides a variety of sleep accessories, including pillows, duvets, and bed bases, all crafted with advanced materials to enhance sleep quality. The company emphasizes the importance of sleep and aims to help customers achieve restorative rest. Simba Sleep sells its products through select retail partners, notably John Lewis, and also operates a robust online platform for direct consumer sales.

Sky Medical Technology Limited is a biomedical device company based in High Wycombe, United Kingdom, specializing in neuromuscular electro-stimulation medical devices. Founded in 2006, the company has developed innovative products such as the geko device, which stimulates the common peroneal nerve to enhance venous blood flow, and the firefly device, designed to aid professional athletes in muscle recovery by improving lower limb circulation. The company’s OnPulse™ technology represents a significant advancement in bioelectronic compression therapy, offering clinically proven solutions for preventing and treating various circulatory conditions, including life-threatening blood clots, post-surgical swelling, and non-healing wounds. Sky Medical Technology's products cater to a range of medical applications and are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, in both clinical practice and studies. The company distributes its devices internationally across multiple regions, including Asia, Europe, and North America.

Vigil is a privately owned New Zealand company founded in 2012. Our​ system improves healthcare outcomes in home based personal healthcare management, hospital and managed care environments. Our industry specific hardware and software packages can be tailored to meet individual customer needs and integrated into existing operational systems, improving cost efficiency, quality of care and healthcare outcomes. They are designed operate with different devices and applications, providing end-to-end connectivity that means device users [wearers], their friends and family and other service providers [carers] can easily access data about the wearer, their wellbeing, their location and their environment.

Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Zilico Limited is a medical diagnostics company focused on developing innovative devices for cancer detection, particularly cervical cancer. Founded in 2006 and based in Manchester, United Kingdom, with an additional office in Sheffield, Zilico utilizes electrical impedance spectroscopy technology to enhance diagnostic accuracy and provide real-time results. Its primary product, ZedScan, is designed to assess cervical epithelial tissue objectively during colposcopy, thereby reducing the subjectivity associated with traditional diagnostic methods. The company is advancing its offerings with two applications aimed at improving referral and screening processes for neoplastic conditions. By enhancing the ability to detect cervical intraepithelial neoplasia, Zilico aims to support healthcare professionals in delivering better diagnostic accuracy and optimizing cancer screening programs.

Oxford Immunotec is a diagnostics company specializing in the development and commercialization of proprietary tests for immunology and infectious diseases. Headquartered in the UK, with operations in the US, the company's core technology, T-SPOT, measures specific T cell responses to inform diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. Its flagship product, T-SPOT.TB, detects active and latent tuberculosis infection, while T-SPOT.CMV monitors cytomegalovirus in transplant recipients. Oxford Immunotec serves independent laboratories, hospital systems, and public and private institutions worldwide.

Alchemy Pharmatech Ltd is a UK-based company founded in 2012 that specializes in developing drug delivery platforms, focusing on intranasal devices for the needle-free delivery of dry powders. The company’s innovative devices aim to enhance the administration of medications, including generic medicines, vaccines, pediatrics, intensive care, and animal health products. By eliminating inter-operator variability, Alchemy's devices provide a smoother and more efficient treatment experience for healthcare professionals and their patients. Their portfolio includes applications for DNA vaccines, hormone replacement therapies, and pain management solutions, highlighting the company's commitment to advancing healthcare through innovative drug delivery technologies.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company utilizes its innovative piezofilm technology platform to create advanced near-patient diagnostic products. Vivacta has successfully developed a test for thyroid stimulating hormone (TSH) and is currently working on a multiple analyte cardiovascular diagnostic test designed for emergency room and acute care settings. This test addresses the need for rapid diagnosis of potential heart attacks and other time-critical medical conditions. By providing high sensitivity and a wide dynamic range comparable to traditional laboratory testing, Vivacta aims to enhance the efficiency and effectiveness of medical diagnostics.

Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Oxford Immunotec is a diagnostics company specializing in the development and commercialization of proprietary tests for immunology and infectious diseases. Headquartered in the UK, with operations in the US, the company's core technology, T-SPOT, measures specific T cell responses to inform diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. Its flagship product, T-SPOT.TB, detects active and latent tuberculosis infection, while T-SPOT.CMV monitors cytomegalovirus in transplant recipients. Oxford Immunotec serves independent laboratories, hospital systems, and public and private institutions worldwide.

Academia.edu is the largest and fastest-growing platform in the world for sharing academic research. Its mission is to accelerate and democratize academic research. Over 150 million academics have signed up to Academia.edu, adding 25 million papers. Over 100,000 people join Academia.edu each day. Academia.edu attracts over 52 million unique visitors a month. 40% of the world's faculty log in to Academia.edu every month. The company was founded in 2008 and is headquartered in San Francisco, California.

Celona Technologies Ltd. specializes in business-centric application data migration software designed to facilitate organizational change. The company offers a comprehensive suite of tailored software solutions that enable seamless migration of applications, data, users, and processes without downtime. Key products include Celona Evolve, which manages the migration and bi-directional synchronization of application data and business processes, along with features such as a management dashboard, migration console, scheduling, reporting, and exception management. Additionally, Celona Technologies provides Application Adaptors that allow for the integration of multiple business application adaptors when transitioning data from legacy systems to new applications. The company serves a diverse range of industries, including telecommunications, financial services, utilities, retail, and the public sector. Founded in 2005 and headquartered in London, the United Kingdom, Celona Technologies has expanded its presence with additional offices in Europe and the Asia Pacific.

Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company utilizes its innovative piezofilm technology platform to create advanced near-patient diagnostic products. Vivacta has successfully developed a test for thyroid stimulating hormone (TSH) and is currently working on a multiple analyte cardiovascular diagnostic test designed for emergency room and acute care settings. This test addresses the need for rapid diagnosis of potential heart attacks and other time-critical medical conditions. By providing high sensitivity and a wide dynamic range comparable to traditional laboratory testing, Vivacta aims to enhance the efficiency and effectiveness of medical diagnostics.

OMGPOP is a prominent developer of social games that caters to various platforms, including Facebook, iPhone, and the open web. The company is recognized for its ability to create engaging real-time game experiences and operates its own destination site, allowing users to enjoy a variety of games. Beyond gaming, OMGPOP offers an online platform where members can interact through chat, share photos, and meet new friends. Additionally, the company retails a range of virtual items, including accessories and game-related merchandise, enhancing user engagement and providing a comprehensive social experience within its gaming ecosystem.

Mind Candy Ltd. is a multi-brand entertainment company based in London, United Kingdom, that specializes in developing online games tailored for children and their families. Founded in 2003, the company is best known for its flagship product, Moshi Monsters, an online browser-based game that engages kids through interactive gameplay. In addition to Moshi Monsters, Mind Candy offers Moshi Monsters Village, a mobile gaming application, and Moshi Monsters Magazine, which features puzzles, stories, competitions, and crafts for children. The company also provides various applications, including Moshi Monsters Music and Moshling, which introduce users to whimsical creatures and musical experiences. Recently, Mind Candy expanded its offerings to include a sleep and mindfulness app for kids, incorporating melodic stories and guided meditation to promote relaxation and mindfulness.

Antenova Ltd is a manufacturer and supplier of standard and custom antenna modules, specializing in radio frequency applications for wireless machine-to-machine (M2M), Internet of Things (IoT), and consumer electronic devices. The company offers a range of products, including gigaNOVA, RADIONOVA, ceriiANT, lamiiANT, flexiiANT, REFLECTOR, and Terminal Antennas, which cater to various applications such as WLAN, Wi-Fi, GPS, and telecoms. In addition to its antenna products, Antenova provides integration, antenna matching and testing, as well as bespoke design services and technical support. Its applications span multiple sectors, including home appliances, automotive, wearables, healthcare, industrial, retail, smart cities, and smart grid. Antenova distributes its products globally through a network of distributors and has operational centers in the United Kingdom, Taiwan, the United States, and China. Founded in 1999, the company is headquartered in Hatfield, United Kingdom.

Secerno is a leading technology company specializing in active database control, headquartered in Oxford, UK, with a US office in Bedminster, New Jersey. The company focuses on database security and compliance, offering innovative solutions through its Secerno DataWall technology. This platform encompasses database activity monitoring, policy enforcement, and compliance auditing, available as both hardware and virtual appliances. Secerno's products are designed to protect against both known and unknown threats, catering to a diverse clientele that includes sectors such as financial services, healthcare, pharmaceuticals, retail, and government agencies.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Kobalt is an independent music services company that provides alternatives to traditional music business models. It focuses on music publishing, label services, and neighboring rights divisions, offering innovative technology solutions aimed at enhancing efficiency and transparency in the music industry. By empowering artists, songwriters, publishers, and labels, Kobalt ensures that each stakeholder is compensated fairly and accurately, navigating the complexities of digital micropayments. The company serves over 8,000 artists and songwriters, managing approximately 600,000 songs and collaborating with more than 450 publishing companies. With a global workforce of over 275 employees, Kobalt delivers real-time reporting through its award-winning Kobalt Portal and offers a range of services, including global licensing management, royalty collection, creative services, and digital marketing. The company represents many prominent artists and songwriters, contributing significantly to the charts in both the US and UK.

Blinkbox Music is an ad-supported music streaming service launched in 2007 and based in Oxford. It offers a platform for listeners to access a vast array of music through thematic radio stations, such as Top 40 Songs and Ultimate 80s Pop, or to create personalized stations starting from their favorite songs, artists, or genres. Users can enjoy Blinkbox Music for free via the web, as well as through mobile and tablet applications available on both Android and iOS devices. The service also allows users to save their favorite stations for offline listening, enhancing their music experience beyond an internet connection.

Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company utilizes its innovative piezofilm technology platform to create advanced near-patient diagnostic products. Vivacta has successfully developed a test for thyroid stimulating hormone (TSH) and is currently working on a multiple analyte cardiovascular diagnostic test designed for emergency room and acute care settings. This test addresses the need for rapid diagnosis of potential heart attacks and other time-critical medical conditions. By providing high sensitivity and a wide dynamic range comparable to traditional laboratory testing, Vivacta aims to enhance the efficiency and effectiveness of medical diagnostics.

Skinkers is a UK-based software developer specializing in communication management solutions. The company focuses on overcoming the limitations of existing digital channels by providing a peer-to-peer network designed for live video streaming and real-time notifications. Skinkers is known for its product Livestation, which streams live video from various official channels, including major news networks. Users can also add their own channels, enhancing the platform's versatility. The company holds the intellectual property rights for technology developed by Microsoft Research, with which it has a strategic partnership, including a minority equity stake from Microsoft. Skinkers aims to establish itself in the competitive peer-to-peer IPTV market, positioning itself against other emerging players in the industry.

EDEM Simulation develops and markets advanced discrete element method (DEM) simulation software, which serves as a crucial tool for simulation-based engineering in industries that handle bulk particles, such as powders, granules, and aggregates. Founded in 2003 and headquartered in Edinburgh, UK, EDEM provides solutions that enhance the design and operation of equipment used in sectors including mining, construction, food processing, and pharmaceuticals. Its flagship EDEM Simulation Software and EDEM BulkSim software offer significant engineering benefits, allowing clients to optimize equipment performance, increase productivity, and reduce design and operational costs. EDEM serves a global clientele, including blue-chip companies, and operates offices in the United States, Japan, and China, while also collaborating with a network of engineering service partners to support the deployment of its simulation technology.

Skinkers is a UK-based software developer specializing in communication management solutions. The company focuses on overcoming the limitations of existing digital channels by providing a peer-to-peer network designed for live video streaming and real-time notifications. Skinkers is known for its product Livestation, which streams live video from various official channels, including major news networks. Users can also add their own channels, enhancing the platform's versatility. The company holds the intellectual property rights for technology developed by Microsoft Research, with which it has a strategic partnership, including a minority equity stake from Microsoft. Skinkers aims to establish itself in the competitive peer-to-peer IPTV market, positioning itself against other emerging players in the industry.

StrategyEye, a B2B intelligence firm, offers a platform that integrates proprietary content with global news and blogs, structured around Companies, Categories, and Trigger Events. It provides two key services: Content Marketing, enabling brands to publish and distribute thought leadership content across multiple channels to boost SEO and generate leads; and Content Monetization, assisting publishers and event organizers in launching premium B2B intelligence products, generating digital revenue through subscriptions or online advertising. StrategyEye also produces its own intelligence products on Digital Media and Cleantech, sold on a subscription basis to over 1,000 executives worldwide.

Mind Candy Ltd. is a multi-brand entertainment company based in London, United Kingdom, that specializes in developing online games tailored for children and their families. Founded in 2003, the company is best known for its flagship product, Moshi Monsters, an online browser-based game that engages kids through interactive gameplay. In addition to Moshi Monsters, Mind Candy offers Moshi Monsters Village, a mobile gaming application, and Moshi Monsters Magazine, which features puzzles, stories, competitions, and crafts for children. The company also provides various applications, including Moshi Monsters Music and Moshling, which introduce users to whimsical creatures and musical experiences. Recently, Mind Candy expanded its offerings to include a sleep and mindfulness app for kids, incorporating melodic stories and guided meditation to promote relaxation and mindfulness.

Skinkers is a UK-based software developer specializing in communication management solutions. The company focuses on overcoming the limitations of existing digital channels by providing a peer-to-peer network designed for live video streaming and real-time notifications. Skinkers is known for its product Livestation, which streams live video from various official channels, including major news networks. Users can also add their own channels, enhancing the platform's versatility. The company holds the intellectual property rights for technology developed by Microsoft Research, with which it has a strategic partnership, including a minority equity stake from Microsoft. Skinkers aims to establish itself in the competitive peer-to-peer IPTV market, positioning itself against other emerging players in the industry.

Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.

Xention Limited is a biopharmaceutical company based in Cambridge, United Kingdom, established in 2002. The company focuses on the discovery and development of innovative ion channel-modulating drugs aimed at addressing significant medical needs. Xention specializes in creating therapies for conditions such as atrial fibrillation, overactive bladder, pain, and autoimmune diseases. By developing drug candidates that target two novel, well-characterized ion channels, Xention seeks to offer breakthrough treatments that enhance current therapeutic options in these areas.

Touch Clarity is a content targeting software company that helps large consumer websites improve customer acquisition and revenue by building real-time, automatic profile data on website visitors and using that data to dynamically target content, adapting propositions as visitor behavior evolves to drive revenue and profit.

LinkGuard's current and future technology solutions focus on the detection, reporting, repair, bypass and prevention of broken links on the Internet.

Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.

Event Zero Pty Ltd, founded in 2005 and headquartered in Eight Mile Plains, Australia, specializes in online content management and software solutions aimed at enhancing IT service operations. The company offers a platform that encompasses data management, business consulting, and interactive article publishing, along with conferencing services. As an independent software vendor, Event Zero focuses on providing products that deliver insights and intelligence, particularly for Microsoft Lync unified communications and green IT initiatives. In 2016, Event Zero became a subsidiary of Microsoft Corporation, further enhancing its capabilities within the technology sector.

Nomad Payments is a leading provider of prepaid and debit card processing and licensed software.